SCM
Squadron Capital Management Portfolio holdings
AUM
$250M
This Fund
S&P 500
1 Year Est. Return
–
AUM
$224M
AUM Growth
–
Holding
33
Top Buys
| 1 | +$22.4M | |
| 2 | +$21.9M | |
| 3 | +$16.8M | |
| 4 |
ABVX
Abivax
ABVX
|
+$15.8M |
| 5 |
KalVista Pharmaceuticals
KALV
|
+$9.27M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Avalo Therapeutics
AVTX
$859M
| $2.36M | 1.05% |
+130,000
|
|
||
|
IVA
27
Inventiva
IVA
$1.06B
| $1.4M | 0.62% |
+300,000
|
|
||
28
Traws Pharma
TRAW
$23.8M
| $806K | 0.36% |
+713,540
|
|
||
|
CLYM
29
Climb Bio
CLYM
$647M
| $400K | 0.18% |
+100,000
|
|
||
|
ZBIO
30
Zenas BioPharma
ZBIO
$1.18B
| – | – |
0
|
|
||
31
Intellia Therapeutics
NTLA
$1.74B
| – | – |
0
|
|
||
32
Vera Therapeutics
VERA
$2.46B
| – | – |
0
|
|
||
33
ArriVent BioPharma
AVBP
$1.28B
| – | – |
0
|
|